Responses
Oncolytic and local immunotherapy
Original research
Targeting NKG2D ligands in glioblastoma with a bispecific T-cell engager is augmented with conventional therapy and enhances oncolytic virotherapy of glioma stem-like cells
Compose a Response to This Article
Other responses
No responses have been published for this article.